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Background: Nur77, a key member of the NR4A receptor subfamily, is involved in the regulation of inflammation
and immunity. However, the in vivo regulatory roles of Nur77 in sepsis and the mechanisms involved remains largely
elusive. In this study, we used Nur77-deficient (Nur77−/−) mice and investigated the function of Nur77 in sepsis.
Findings: Compared to wild-type (Nur77+/+) mice, Nur77−/− mice are more susceptible to LPS-induced sepsis and
acute liver inflammation. Mechanistically, we observed that Nur77 can interact with TRAF6, a crucial adaptor molecule
in the Toll-like receptor-interleukin 1 receptor (TLR-IL-1R) signalling pathway, in in vivo mouse model of sepsis. The
interaction may affect TRAF6 auto-ubiquitination, thereby inhibiting NF-κB activation and pro-inflammatory cytokines
production.
Conclusions: These in vivo observations reveals an important protective role for Nur77 in LPS-induced sepsis through
its regulation to TRAF6 signalling, and highlights the potential clinical application of Nur77 as a molecular target
in prevention and/or treatment of sepsis.
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Orphan nuclear receptor Nur77 (also called TR3, NGFI-
B, or NR4A1) is a member of the NR4A family of nu-
clear receptors. Similar to other nuclear receptors,
Nur77 consists of an N-terminal transactivation domain,
a central DNA binding domain and a C-terminal ligand
binding domain, and can act in the nucleus as a ligand-
independent and constitutively active transcription factor
by binding to its DNA response elements as monomers
[1], homodimers [2] or heterodimers with retinoid X re-
ceptor [2]. Unlike other nuclear receptors, Nur77 and
other members of the subfamily are classified as early re-
sponse genes whose expression is induced by a diverse
range of extracellular stimuli including a wide array of cy-
tokines and growth factors [3]. Consistently, accumulating
studies indicate that Nur77 is implicated in the control of
inflammatory diseases including atherosclerosis [4], arth-
ritis [5], inflammatory bowel disease (IBD) [6] and cancer* Correspondence: wuhua@suda.edu.cn
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lesions [8], and cancer [7]. Nur77 may act to mediate pro-
inflammatory signalling by increasing the expression of
NF-κB-activating kinase, IKKi [9] to attenuate cytokine
signalling. However, recent in vivo studies have shown
that Nur77 is protective against the development of ath-
erosclerosis by regulating the polarization of macrophages
and subsequently inhibits inflammatory responses [10], in-
dicating Nur77 may mediate anti-inflammatory signalling.
Despite all of these efforts, however, the in vivo roles and
underlying mechanism of Nur77 in sepsis are unclear.
Tumor necrosis factor receptor associated factor 6
(TRAF6), a member of TRAF family, is a common sig-
nalling mediator for the TLR-IL-1R superfamily [11].
TRAF6-deficient mice have defects in TLR-IL-1R-initi-
ated inflammatory signalling [12]. TRAF6 is reported to
possess an E3 ubiquitin ligase and undergoes lysine 63
(K63)-linked auto-ubiquitination [13]. The modifica-
tion, in contrast to K48-linked polyubiquitin conjuga-
tion, is not associated with proteasomal degradation
but instead facilitates signal transduction and protein
trafficking [14, 15]. The regulatory involvement of various
molecules in TRAF6-mediated TLR-IL-1R signalling hasstributed under the terms of the Creative Commons Attribution 4.0 International
by/4.0/), which permits unrestricted use, distribution, and reproduction in any
t to the original author(s) and the source, provide a link to the Creative
re made. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
Table 1 Primers for real-time PCR
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prevent ubiquitination of TRAF6 through direct inter-
action, which effectively blocks excessive inflammatory re-
sponses [16]. In contrast, the formation of TRAF6-HSP27
complex promotes TRAF6 ubiquitination and enhances
activation of NF-κB signalling triggered by IL-1β [17].
Here, we investigate the in vivo function of Nur77 in
sepsis and sepsis-associated liver injury. Our work indi-
cates that Nur77 deficiency in mice increased their
susceptibility to LPS-induced sepsis and acute liver injury,
and reveal a critical mechanism wherein Nur77 interacts
with TRAF6 and regulate its auto-ubiquitination in in vivo
mouse model of sepsis.
Materials and methods
Mice
Nur77-knockout mice were purchased from Jackson
Laboratory (Bar Harbor, ME). Mice were maintained in
a pathogen-free environment as recently described [6].
All animal experiments were performed in accordance
with the regulations and guidelines of the Animal Care
and Use Committee of Soochow University.
Sepsis model
The age- and sex-matched Nur77+/+ versus Nur77−/− mice
were injected with LPS (20 mg/kg, ip). Then, 2 h later,
hepatic Tnf, Il6, and Il12b mRNA was measured by RT-
PCR and Real-time PCR. TNFα and IL-6 in blood were
measured with ELISA. To induce endotoxic shock, mice
were injected with LPS (20 mg/kg, ip) and were monitored
for survival for the ensuing 72 h.
Acute liver injury model
Nur77+/+ and Nur77−/− mice used for the model were
8–10 weeks of age and were matched for age and sex.
Mice were co-injected with LPS (5 μg/kg, ip) and D-
GalN (400 mg/kg). 5 h later, mice were anesthetized with
ether and retro-orbitally bled. ALT, AST, TNFα, and IL-
6 were measured with ELISA. Also, RNA was extracted
from liver tissue and relative mRNA of Tnf, Il6, and
Il12b were measured by RT-PCR and Real-time PCR.
Mice were monitored for 24 h to assess survival.
Tissue samples collection and evaluation
Pathological analysis of lung, liver and kidney from
Nur77+/+ and Nur77−/− mice was conducted and tissue
samples were fixed in 10 % buffered formalin and then
embedded in paraffin. Tissue was sectioned and stained
with hematoxylin and eosin (H&E) according to stand-
ard histological procedures.
Real-time PCR assays
Real-time PCR assays were performed as published [7, 18].
The abundance of each mRNA was normalized relative toPCR with the housekeeping gene β-actin. The primers for
PCR reactions are listed in Table 1.
ELISA
ALT, AST, TNFα, and IL-6 in serum were measured with
commercially available kits according to the manufac-
turer’s instructions.
Western blot
Western blot analyses were performed as described in
the literature [7].
Immunoprecipitation and ubiquitination Assay
Cells were lysed in lysis buffer (2 mmol/L Tris–HCl
(pH 7.4), 10 mmol/L EDTA, 100 mmol/L NaCl and 1 %
IGEPAL). Cell lysates were incubated with indicated
antibodies in protein A/G beads (Santa Cruz Biotechnol-
ogy) for 3 h. Then, the protein-antibody complexes on
the beads were analyzed with Western blot. To measure
TRAF6 ubiquitination, 10 mM N-ethylmaleimide (Sigma)
was included in the lysis buffer.
Statistical analysis
Data are expressed as means ± SD, and Student’s t test
(unpaired, two-tailed) was used to compare two groups
of independent samples (p < 0.05 were considered statis-
tically significant).
Results and discussion
Research suggests that orphan nuclear receptor Nur77 is
implicated in inflammation and immunity. Mice lacking
all Nr4a receptors including Nur77 did not generate Treg
cells and resulted in systemic autoimmune disease [19].
Nur77 deficiency in mice lead to acceleration of athero-
sclerosis [10] and inflammatory bowel disease [6]. We
recently reported that loss of Nur77 in older mice contrib-
utes to systemic inflammation [20]. Sepsis, the major com-
plication of severe infection, usually causes multisystem
organ failure and even death of many patients in hospital
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potential targets for sepsis treatment. Here we investigate
in vivo functions of Nur77 in sepsis and sepsis-associated
liver injury. We first challenged Nur77−/− mice with LPS
to ascertain the role of Nur77 in LPS-induced sepsis
in vivo. After treatment with LPS, lungs of Nur77−/− mice
had severe inflammatory hyperemia, as evidenced by
increased mononuclear cells and erythrocyte infiltration
(Fig. 1a). RT-PCR and Real-time PCR assays, in liver tis-
sues from Nur77−/− mice, showed substantial induction of
Tnf and Il6 expression (Fig. 1b). Consistent with these re-
sults, levels of TNFα and IL-6 in serum were significantly
higher in LPS-treated Nur77−/− mice than in LPS-treated
Nur77+/+ mice (Fig. 1c), suggesting that the host response




Fig. 1 Mice deficient in Nur77 are more susceptible to LPS-induced sepsis.
after challenge with PBS or LPS (20 mg/kg). Representative images are sho
and Real-time PCR (right) quantification of expression of hepatic Tnf and Il6
or LPS (20 mg/kg). Error bars represent means ± SD from 3 biological replic
in serum of LPS-treated Nur77+/+ mice (n = 5) and LPS-treated Nur77−/− mi
Nur77+/+ mice (n = 7) and Nur77−/− mice (n = 8) treated with LPS and monLPS, Nur77−/− mouse survival was reduced (Fig. 1d).
These results are consistent with a recent report that mice
lacking Nur77 had exacerbated inflammatory and immune
responses, and survival was decreased after lethal endo-
toxemic challenge [22]. Thus, Nur77 is important for
modulation of inflammatory responses during sepsis.
To further ascertain the role of Nur77 in sepsis, we
treated mice with LPS/D-GalN known to induce acute
liver injury. At 5 h after LPS/D-GalN challenge, Nur77−/−
mice had severe hepatocyte destruction compared to wild-
type mice (Fig. 2a). LPS/D-GalN injection also promoted
hepatocyte cell death in Nur77−/− mice revealed by PARP
cleavage (Fig. 2b). ALT and AST, liver function markers,
were also significantly greater in serum from LPS/D-
GalN-treated Nur77−/− mice (Fig. 2c), indicating increaseda Histological analysis of lungs from Nur77+/+ and Nur77−/− mice 6 h
wn. Scale bars, 100 μM. Original magnification, 100x. b RT-PCR (left)
mRNA from Nur77+/+ and Nur77−/− mice 2 h after challenge with PBS
ates. *p < 0.05 and **p < 0.01. c ELISA assay of TNFα and IL-6 expression
ce (n = 5). Error bars represent means ± SD. **p < 0.01. d Survival of





Fig. 2 Nur77−/− mice have increased susceptibility to LPS/D-GalN-induced acute liver injury. a H&E staining of livers from Nur77+/+ and Nur77−/− mice
5 h after injection with LPS/D-GalN. Representative images are shown. Scale bars, 100 μM. Original magnification, 100x. b Liver extracts assessed by
Western blot and indicated antibodies. c ELISA of serum ALT and AST from Nur77+/+ and Nur77−/− mice 5 h after injection with LPS/D-GalN or PBS.
Error bars represent means ± SD. *p < 0.05 and **p < 0.01. d Tnf, Il6 and Il12 mRNA expression was measured with RT-PCR (left) and qPCR
(right) in livers from Nur77+/+ and Nur77−/− mice 2 h after treatment with LPS/D-GalN. Error bars represent means ± SD from 3 biological
replicates. *p < 0.05 and **p < 0.01. e ELISA quantification of serum TNFα, IL-6 from Nur77+/+ and Nur77−/− mice after treatment with LPS/
D-GalN for 5 h. Error bars represent means ± SD. *p < 0.05
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sion as these are known to be involved in this model of
acute liver inflammation [23, 24] in liver tissues from
wild-type and Nur77−/− mice. RT-PCR and real-time PCR
assays confirmed that expression of these pro-inflammatory
cytokines mRNA was greater in LPS/D-GalN-treated
Nur77−/− mice than in wild-type mice (Fig. 2d). Similarly,
generation of inflammatory cytokines including TNFα and
IL-6 were markedly enhanced in serum from Nur77−/−
mice (Fig. 2e). Thus, Nur77 is protective against LPS-
induced acute liver injury.The molecular mechanism by which Nur77 defi-
ciency promotes sepsis remains obscure. Nur77 has
been shown to inhibit LPS-induced inflammation by
inhibiting p65 binding to DNA, thereby reducing pro-
inflammatory cytokine production [25]. We observed
enhanced phosphorylation and degradation of IκBα
was in liver and spleen tissues from Nur77−/− mice
challenged with LPS (Fig. 3a), indicating Nur77 could
suppress LPS-induced NF-κB activity in vivo. Also
Nur77 contributes to regulation of TRAF6 signalling




Fig. 3 Nur77 inhibits inflammatory response in in vivo mouse model of sepsis by interacting with TRAF6 and regulating TRAF6 auto-ubiquitination
(a) Immunoblot analysis of indicated signalling proteins in liver (left) and spleen (right) from Nur77+/+ and Nur77−/− mice 2 h after LPS (20 mg/kg)
challenge. b Immunoprecipitation and immunoblot of liver and spleen proteins from C57BL/6 mice 1 h after LPS (20 mg/kg) treatment.
c Immunoprecipitation of endogenous TRAF6 from liver (left) and spleen (right) lysates of LPS-treated Nur77+/+ and Nur77−/− mice, and
immunoblot of TRAF6 auto-ubiquitination with anti-ubiquitin antibody. d Immunoprecipitation of endogenous TRAF6 from lysates of LPS-treated
(50 ng/ml) RAW264.7 cells expressing vector or myc-tagged Nur77 plasmid and immunoblotted for TRAF6 auto-ubiquitination with an
anti-ubiquitin antibody
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hanced Nur77-TRAF6 interaction in the liver and
spleen compared to control PBS-treated mice. These
results are consistent with our recent observation that
disruption of Nur77-TRAF6 interaction in Nur77−/−
mice accelerated the development of IBD [6]. Collect-
ively, these data suggest that Nur77 physically inter-
acts with TRAF6 in in vivo mouse model of sepsis,
revealing a pathophysiological significance of Nur77-
TRAF6 interaction in sepsis. Auto-ubiquitination of
TRAF6 is required for NF-κB signal transduction
[16]. Here, our results showed that Nur77 deficiency
significantly enhanced auto-ubiquitination of TRAF6
in liver and spleen tissues prepared from Nur77−/−
but not wild-type mice (Fig. 3c). At the same time,overexpression of Nur77 significantly impaired LPS-
induced TRAF6 auto-ubiquitination (Fig. 3d). Also we in-
vestigated whether Nur77 can affect auto-ubiquitination
of TRAF3, another member of the TRAF family but we
observed no significant change. Additional file 1: Figure
S1 indicates that overexpression of Nur77 did not affect
TRAF3 auto-ubiquitination induced by LPS, suggesting
that Nur77 is important in regulating LPS-induced inflam-
mation by targeting TRAF6.
In summary, our in vivo study confirmed a critical
protective role for the orphan nuclear receptor
Nur77 in sepsis and identify a key mechanism for
Nur77 in the regulation of TRAF6 signalling through
its interaction with TRAF6 in in vivo mouse model
of sepsis.
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Additional file 1: Figure S1. Nur77 does not affect auto-ubiquitination
of TRAF3 induced by LPS. Immunoprecipitation of endogenous TRAF3
from lysates of LPS-treated (50 ng/ml) RAW264.7 cells expressing vector
or myc-tagged Nur77 plasmid, immunoblotted for TRAF3 auto-ubiquitination
with an anti-ubiquitin antibody. (PDF 62 kb)
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